NCT02094365View on ClinicalTrials.gov

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

ALS-008176

DRUG

vehicle

Trial Locations (1)

Unknown

Retroscreen Virology Ltd, London

Sponsors
All Listed Sponsors
lead

Alios Biopharma Inc.

INDUSTRY

NCT02094365 - A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model | Biotech Hunter | Biotech Hunter